Bulletin
Investor Alert

Market Pulse Archives

May 25, 2022, 9:57 a.m. EDT

Teva Pharmaceutical to pay $110 mln to settle opioid charges in W. Va.

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Teva Pharmaceutical Industries Ltd. ADR (TEVA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Steve Gelsi

Teva Pharmaceutical Industries Ltd. /zigman2/quotes/205657894/composite TEVA -5.41% said Wednesday it agreed to make $110 million in payments to settle opioid claims against it by West Virginia. The company will pay $75 million over 15 years plus $8 million for legal fees. It will also provide $27 million worth of the generic version of Narcan over 10 years. Teva said the settlement is "consistent with previously announced settlement as it continues to negotiate a national settlement. Teva did not admit any liability or wrongdoing as part of the deal. Shares of Teva rose 2.2% on Wednesday morning. The stock is up 7.8% so far this year, compared to a loss of 17.2% by the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.88% .

/zigman2/quotes/205657894/composite
US : U.S.: NYSE
$ 7.52
-0.43 -5.41%
Volume: 12.18M
June 30, 2022 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$8.84 billion
Rev. per Employee
$413,885
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,785.38
-33.45 -0.88%
Volume: 2.68B
June 30, 2022 5:30p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.